Age- and weight-related dosage of dDAVP in the treatment of primary nocturnal enuresis;Alters- und gewichtsbezogene dosierung von dDAVP in der therapie der primären enuresis nocturna

Klinische Padiatrie

Volumn 213, Issue 6, 2001, Pages 317-320

  Eggert, P ^a   Chavez Kattau, K ^a   Muller D ^a  

^a UNIVERSITY OF KIEL   (Germany)

Author keywords

dDAVP; Dose response; Enuresis nocturna

Indexed keywords

DESMOPRESSIN;

ADOLESCENT; AGE; ARTICLE; BODY WEIGHT; CHILD; CLINICAL ARTICLE; DOSE RESPONSE; FEMALE; HUMAN; MALE; NOCTURNAL ENURESIS; PRACTICE GUIDELINE; STANDARDIZATION;

ADMINISTRATION, INTRANASAL; ADOLESCENT; AGE FACTORS; BODY WEIGHT; CHILD; DEAMINO ARGININE VASOPRESSIN; DOSE-RESPONSE RELATIONSHIP, DRUG; ENURESIS; FEMALE; HUMANS; MALE; PROSPECTIVE STUDIES; TREATMENT OUTCOME; URODYNAMICS;

EID: 0035189275     PISSN: 03008630     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2001-18458     Document Type: Article

References (10)

1. Disorders of elimination
2. Antidiuretic approach with dDAVP for nocturnal enuresis
3. Regulation of arginine vasopressin in enuretic children under fluid restriction
4. Voiding dysfunction
5. Treatment with Desmopressin in severe nocturnal enuresis
6. Effect of dDAVP on Nocturnal Enuresis in a Patient with Nephrogenic Diabetes Insipidus
7. Desmopressin acetate in children with severe primary nocturnal enuresis
8. AVP acetate and nocturnal enuresis: How much do we know?
9. Abnormal diurnal rhythm of plasma vasopressin and urinary output in patients with enuresis
10. Desmopressin in nocturnal enuresis